Drugs Market Research Reports
The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
... as extensive listings of companies developing and marketing innovative technologies and products. This report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, new ...
May, 2013 549 pages... shares) $5,500. This new 313-page report from Venture Planning Group contains 83 tables and provides analysis of the global therapeutic ... as specimen preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market: US, Europe (France, Germany, Italy, Spain, UK), Japan” ...
May, 2013 313 pages... shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for ... , such as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan” ...
May, 2013 318 pages... and royalties by stage of development Antibiotics partnering contract documents Top antibiotics deals by value The Antibiotics Partnering Terms and Agreements report provides an ... How aresalesand payments audited? What is the deal term? How are the key terms of the agreement defined? How are IPRs handled ...
May, 2013 340 pages... their dynamics, trends, structure, size, growth and major suppliers. Five-year test volume and reagent sales forecasts for drugs of ... Offices/Group Practices Emergency Rooms Ambulatory Care Centers Analysis of drugs of abuse procedures Competitive Assessments Assessments of major POC suppliers and ...
May, 2013 194 pagesThis report analyzes the worldwide markets for Ion Channel Modulators in US$ Million. The report provides separate comprehensive analytics for the US, ... Ltd., Renesas Electronics Corporation, VIA Technologies, Inc., and Zilog, Inc. Market data and analytics are derived from primary and secondary research. ...
Mar, 2013 404 pages... vendors could pose a challenge to the growth of this market. TechNavio's report, Global Proteomics Market 2012-2016, has been prepared based on an in-depth market ... . The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this space are Thermo Fischer ...
Apr, 2013 44 pages... the end of the review period, all triptans remained Rx in Kazakhstan. Euromonitor International's OTC Triptans in Kazakhstan report offers a comprehensive guide to the ... data. Why buy this report? Get a detailed picture of the OTC Triptans market; Pinpoint growth sectors and identify factors driving ...
Apr, 2013 16 pages... suffering from migraines if this diagnosis is approved. Euromonitor International's OTC Triptans in Azerbaijan report offers a comprehensive guide to the size and shape of ... data. Why buy this report? Get a detailed picture of the OTC Triptans market; Pinpoint growth sectors and identify factors driving ...
Apr, 2013 16 pagesEmergency contraception products in Kazakhstan are Rx, since they might be overused, particularly by younger consumers. Euromonitor International's Emergency Contraception in Kazakhstan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail ...
Apr, 2013 16 pagesChina's demand for alzheimer disease treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry ...
Apr, 2013 207 pagesChina's demand for prescription drugs has grown at a fast pace in the past decade. In the next five years, both production and demand ... environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and ...
Apr, 2013 192 pages... Squibb Novartis Pfizer Sanofi As indicted in the study, the thrombotic drugs segment is currently small, but holds great growth potential in the ... industry leaders with a competitive benchmarking of the world’s top five cardiovascular drugs companies. The study provides up-to-date information on the market ...
Dec, 2012... , has analyzed the global diabetes drugs industry and presents its findings in “Global Diabetes Drugs Industry 2013-2018: Trend, Profit, ... will save Lucintel clients hundreds of hours in personal research time on a global market and it offers significant benefits in expanding business opportunities throughout ...
Jan, 2013... and offers its findings in its research report, “Global Cardiovascular Drugs Industry 2012-2017: Trend, Profit, and Forecast Analysis.” The ... and affected by government regulations in different regions and countries. The global market is geographically segmented into North America, Europe, Asia Pacific (APAC ...
Jul, 2012... Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Osteoporosis - US Drug Forecast and Market Analysis to 2022”. Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 and 2022. Most importantly, ...
Feb, 2013 136 pages... Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Osteoporosis - UK Drug Forecast and Market Analysis to 2022”. Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 and 2022. Most importantly, ...
Feb, 2013 128 pages... Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Osteoporosis - Spain Drug Forecast and Market Analysis to 2022”. Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 and 2022. Most importantly, the ...
Feb, 2013 123 pages... Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Osteoporosis - Japan Drug Forecast and Market Analysis to 2022”. Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 and 2022. Most importantly, the ...
Feb, 2013 125 pages... Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Osteoporosis - Italy Drug Forecast and Market Analysis to 2022”. Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 and 2022. Most importantly, the ...
Feb, 2013 127 pages
